PDE4-IN-14

• CAS Number:

  2231329-25-0

• UNSPSC Description:

  PDE4-IN-14 (Compound 1) is a PDE4 inhibitor that can be used in the study of PDE4-related diseases (such as inflammatory and immune diseases, cancer, and metabolic diseases, etc.)[1].

• Target Antigen:

  Phosphodiesterase (PDE)

• Type:

  Reference compound

• Related Pathways:

  Metabolic Enzyme/Protease

• Applications:

  Metabolism-protein/nucleotide metabolism

• Field of Research:

  Cancer; Metabolic Disease; Inflammation/Immunology; Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/pde4-in-14.html

• Solubility:

  DMSO : 100 mg/mL (ultrasonic)

• Smiles:

  FC(OC1=C2N=C(N3CC4NC(C4)C3)OC2=C(C5=NC=CS5)C=C1)(C(C)(C)O)F

• Molecular Weight:

  422.45

• References & Citations:

  [1]Ko KUMURA, et al. Crystal of benzoxazole derivative. Patent CA3104829A1.

• Shipping Conditions:

  Room Temperature

• Clinical Information:

  No Development Reported